Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05009225 · ClinicalTrials.gov registry record
Clinical Decision Support for Atrial Fibrillation and Flutter
A clinical trial of Atrial Fibrillation and Flutter, sponsored by Kaiser Permanente.
- Active
- Registry status
- 4,000
- Enrollment target
- 16
- Study locations
NCT05009225 is a study of Atrial Fibrillation and Flutter that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 4,000 participants. The trial reports 16 study locations across 1 state.
The verdict
NCT05009225, a study of Atrial Fibrillation and Flutter, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
Atrial fibrillation (AF) is a major public health problem: it impairs quality of life and independently heightens the risks of ischemic stroke, heart failure and all-cause mortality. AF is a common reason for presenting to emergency departments (ED) in Kaiser Permanente Northern California (KPNC) and is associated with frequent hospitalization. Additionally, inter-facility hospitalization rates for AF vary across KPNC. Improvements in modifiable components of ED AF care could potentially reduce low-yield hospitalizations and the associated costs, patient inconveniences, and complications that can ensue. Real-time clinical decision support systems (CDSS) can transform entrenched physician practices and improve patient outcomes. The investigators will conduct a stepped-wedge cluster randomized trial of a CDSS intervention across 13 KPNC EDs for the comprehensive management of acute AF with the following three aims: 1) To evaluate the impact of the CDSS intervention on index hospitalization rates; 2) To evaluate the impact of the CDSS intervention on ED AF rate and rhythm control process-of-care metrics; and 3) To evaluate the impact of the CDSS intervention on AF stroke prevention actions for eligible participants at the time of ED discharge. The investigators hypothesize that the CDSS intervention will safely reduce index hospitalization rates, improve rate and rhythm control process-of-care metrics, and increase stroke prevention actions for eligible participants at ED discharge and within 30 days.
Conditions Studied
Interventions
- OTHER Comprehensive ED AF management tool
Study Locations (16)
California
- Kaiser Permanente Antioch Emergency Department - Antioch
- Kaiser Permanente Fremont Emergency Department - Fremont
- Kaiser Permanente Manteca Medical Center - Manteca
- Kaiser Permanente Modesto Medical Center - Modesto
- Kaiser Permanente Oakland Emergency Department - Oakland
- Kaiser Permanente Richmond Emergency Department - Richmond
- Kaiser Permanente Roseville Emergency Department - Roseville
- Kaiser Permanente South Sacramento Emergency Department - Sacramento
- Kaiser Permanente Sacramento Emergency Department - Sacramento
- Kaiser Permanente San Francisco Emergency Department - San Francisco
- Kaiser Permanente San Jose Emergency Department - San Jose
- Kaiser Permanente San Leandro Emergency Department - San Leandro
- Kaiser Permanente San Rafael Emergency Department - San Rafael
- Kaiser Permanente Santa Clara Emergency Department - Santa Clara
- Kaiser Permanente South San Francisco Emergency Department - South San Francisco
- Kaiser Permanente Walnut Creek Medical Center - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05009225
The ClinicalTrials.gov registry entry for NCT05009225 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation and Flutter appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive ED AF management tool is the first listed.
NCT05009225 reports 16 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05009225 about?
NCT05009225 is a clinical study titled "Clinical Decision Support for Atrial Fibrillation and Flutter". Atrial fibrillation (AF) is a major public health problem: it impairs quality of life and independently heightens the risks of ischemic stroke, heart failure and all-cause mortality. AF is a common reason for presenting to emergency departments (ED) in Kaiser Permanente Northern California (KPNC) an...
What is the current status of trial NCT05009225?
This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2021-10-01. Estimated completion is 2024-06-30.
What conditions does trial NCT05009225 study?
This clinical trial studies the following conditions: Atrial Fibrillation and Flutter.
What interventions are being tested in trial NCT05009225?
The interventions under investigation include: Comprehensive ED AF management tool (OTHER).
Who is sponsoring clinical trial NCT05009225?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05009225 being conducted?
This trial has 16 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.